SELLAS Life Sciences (SLS) EPS (Basic) (2011 - 2026)
SELLAS Life Sciences' (SLS) quarterly EPS (Basic) came in at -$0.09 in Q1 2026, down 22.29% year-on-year from -$0.11 in Q1 2025, and down 13.91% on a QoQ basis from -$0.08 in Q4 2025.
SELLAS Life Sciences (SLS) EPS (Basic) (2011 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 16 years of EPS (Basic) data on file, last reported at -$0.09 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 22.29% year-over-year to -$0.09 in Q1 2026; TTM through Mar 2026 was -$0.23, a 29.09% increase from a year earlier, with the FY2025 full-year figure at -$0.47, up 45.23% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.09, down from -$0.08 in the prior quarter.
- Over the last five years, EPS (Basic) for SLS reached as high as -$0.07 in Q3 2025 and fell as low as -$1.06 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.28 across 5 years, with a median of -$0.22 in 2024.
- Across the five-year window, EPS (Basic) slumped 555.63% in 2022 and jumped 67.38% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.5 in 2022, then surged by 40.08% to -$0.3 in 2023, then jumped by 61.52% to -$0.11 in 2024, then surged by 33.19% to -$0.08 in 2025, then retreated by 13.91% to -$0.09 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.09 in Q1 2026, -$0.08 in Q4 2025, and -$0.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.32 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.50 |
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -1.06 |
| Dec 31, 2021 | -0.43 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -0.30 |